Ensign Group (ENSG) Stock Price

Ensign Group Price

NASDAQ·CLOSED
180.76USD+13.24 (+7.60 %)
Market closed

Over the last 19 years Ensign Group grew revenue by 14.9% annually, reaching 5.06 B USD. Earnings per share have grown at 10.7% per year over the last 19 years. For Ensign Group, the net margin of 6.8% is broadly stable versus 7.4% a few years ago. At today's price the dividend yield works out to roughly 0.14%. The payout ratio is around 4% of earnings. The dividend has grown at 10.8% per year over the past 18 years. The consensus 12-month price target for Ensign Group is 210.12 USD, about 16.2% above where the stock trades today. Of 11 analysts, 9 rate the stock a buy — an overall Buy consensus. The stock trades about 22% above its 52-week low.

Ensign Group stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Ensign Group over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Ensign Group stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Ensign Group's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Ensign Group Stock Price History
DateEnsign Group Price
7/27/2026180.76 USD
7/23/2026167.52 USD
7/22/2026169.11 USD
7/21/2026170.87 USD
7/20/2026172.04 USD
7/17/2026171.28 USD
7/16/2026172.89 USD
7/15/2026167.38 USD
7/14/2026166.73 USD
7/13/2026169.50 USD
7/10/2026168.59 USD
7/9/2026168.92 USD
7/8/2026170.30 USD
7/7/2026170.87 USD
7/6/2026167.73 USD
7/2/2026168.22 USD
7/1/2026164.82 USD
6/30/2026160.30 USD
6/29/2026158.31 USD
6/26/2026163.05 USD
6/25/2026165.74 USD
6/24/2026164.07 USD
6/23/2026158.89 USD
6/22/2026154.49 USD
6/18/2026154.40 USD
6/17/2026157.51 USD
6/16/2026157.95 USD
6/15/2026150.69 USD
6/12/2026148.30 USD
6/11/2026152.39 USD
6/10/2026153.82 USD
6/9/2026155.25 USD
6/8/2026156.42 USD
6/5/2026169.41 USD
6/4/2026166.69 USD
6/3/2026165.98 USD
6/2/2026164.82 USD
6/1/2026165.01 USD
5/29/2026168.58 USD
5/28/2026169.83 USD
5/27/2026172.02 USD
5/26/2026170.58 USD
5/22/2026170.66 USD
5/21/2026174.41 USD
5/20/2026176.56 USD
5/19/2026175.89 USD
5/18/2026176.66 USD
5/15/2026177.67 USD
5/14/2026179.26 USD
5/13/2026178.00 USD
5/12/2026176.04 USD
5/11/2026169.41 USD
5/8/2026171.45 USD
5/7/2026174.30 USD
5/6/2026175.93 USD
5/5/2026175.95 USD
5/4/2026182.03 USD
5/1/2026183.72 USD
4/30/2026186.69 USD
4/29/2026186.40 USD
4/28/2026188.30 USD
4/27/2026189.94 USD
4/24/2026189.16 USD
4/23/2026189.34 USD
4/22/2026186.22 USD
4/21/2026191.74 USD
4/20/2026197.55 USD
4/17/2026200.11 USD
4/16/2026197.72 USD
4/15/2026197.92 USD
4/14/2026198.45 USD
4/13/2026200.30 USD
4/10/2026199.02 USD
4/9/2026201.56 USD
4/8/2026204.79 USD
4/7/2026200.39 USD
4/6/2026197.98 USD
4/2/2026196.62 USD
4/1/2026200.10 USD
3/31/2026201.50 USD
3/30/2026200.41 USD
3/27/2026200.66 USD
3/26/2026201.99 USD
3/25/2026203.89 USD
3/24/2026202.92 USD
3/23/2026202.43 USD
3/20/2026200.08 USD
3/19/2026202.49 USD
3/18/2026202.49 USD
3/17/2026210.38 USD
3/16/2026209.46 USD
3/13/2026209.71 USD
3/12/2026208.36 USD
3/11/2026210.43 USD
3/10/2026209.65 USD
3/9/2026209.97 USD
3/6/2026207.23 USD
3/5/2026207.30 USD
3/4/2026212.05 USD
3/3/2026213.13 USD
3/2/2026215.83 USD
2/27/2026214.17 USD
2/26/2026212.65 USD
2/25/2026213.84 USD
2/24/2026212.39 USD
2/23/2026214.17 USD
2/20/2026210.64 USD
2/19/2026203.51 USD
2/18/2026209.96 USD
2/17/2026212.47 USD
2/16/2026212.47 USD
2/13/2026213.34 USD
2/12/2026213.34 USD
2/11/2026214.41 USD
2/10/2026211.92 USD
2/9/2026203.93 USD
2/8/2026199.29 USD
2/6/2026197.80 USD
2/5/2026197.80 USD
2/4/2026197.16 USD
2/3/2026173.18 USD
2/2/2026173.60 USD
2/1/2026172.56 USD
1/30/2026171.66 USD
1/29/2026171.66 USD
1/28/2026170.06 USD
1/27/2026171.80 USD
1/26/2026171.99 USD
1/25/2026178.15 USD
1/23/2026175.46 USD
1/22/2026175.46 USD
1/21/2026174.99 USD
1/20/2026177.88 USD
1/19/2026177.41 USD
1/16/2026180.57 USD
1/15/2026180.57 USD
1/14/2026183.54 USD
1/13/2026177.58 USD
1/12/2026177.87 USD
1/11/2026176.73 USD
1/9/2026173.87 USD
1/8/2026173.87 USD
1/7/2026176.21 USD
1/6/2026178.38 USD
1/5/2026179.65 USD
1/4/2026176.52 USD
1/2/2026173.92 USD
1/1/2026173.92 USD
12/31/2025174.20 USD
12/30/2025174.20 USD
12/29/2025176.72 USD
12/28/2025176.33 USD
12/26/2025176.44 USD
12/25/2025176.44 USD
12/24/2025176.66 USD
12/23/2025176.66 USD
12/22/2025178.60 USD
12/21/2025179.03 USD
12/19/2025181.39 USD
12/18/2025181.39 USD
12/17/2025176.95 USD
12/16/2025176.57 USD
12/15/2025175.36 USD
12/14/2025177.09 USD
12/12/2025175.63 USD
12/11/2025175.63 USD
12/10/2025174.15 USD
12/9/2025173.58 USD
12/8/2025174.14 USD
12/7/2025175.39 USD
12/5/2025177.97 USD
12/4/2025177.97 USD
12/3/2025177.94 USD
12/2/2025178.99 USD
12/1/2025181.15 USD
11/30/2025183.63 USD
11/28/2025185.54 USD
11/27/2025185.54 USD
11/26/2025186.96 USD
11/25/2025186.96 USD
11/24/2025187.53 USD
11/23/2025184.58 USD
11/21/2025184.99 USD
11/20/2025184.99 USD
11/19/2025179.34 USD
11/18/2025178.71 USD
11/17/2025178.50 USD
11/16/2025177.56 USD
11/14/2025177.89 USD
11/13/2025177.89 USD
11/12/2025177.30 USD
11/11/2025179.79 USD
11/10/2025179.80 USD
11/9/2025181.52 USD
11/7/2025179.97 USD
11/6/2025179.97 USD
11/5/2025182.91 USD
11/4/2025189.93 USD
11/3/2025183.98 USD
11/2/2025183.88 USD
10/31/2025180.10 USD
10/30/2025180.10 USD
10/29/2025180.31 USD
10/28/2025182.70 USD
10/27/2025185.64 USD
10/26/2025186.50 USD
10/23/2025186.05 USD
10/22/2025185.37 USD
10/21/2025184.79 USD
10/20/2025183.15 USD
10/19/2025185.40 USD
10/16/2025182.04 USD
10/15/2025179.47 USD
10/14/2025177.94 USD
10/13/2025178.00 USD
10/12/2025177.01 USD
10/9/2025175.34 USD
10/8/2025175.93 USD
10/7/2025176.35 USD
10/6/2025176.50 USD
10/5/2025177.22 USD
10/2/2025175.40 USD
10/1/2025173.93 USD
9/30/2025174.45 USD
9/29/2025172.77 USD
9/28/2025171.55 USD
9/25/2025172.50 USD
9/24/2025169.97 USD
9/23/2025170.32 USD
9/22/2025166.76 USD
9/21/2025166.82 USD
9/18/2025164.29 USD
9/17/2025167.07 USD
9/16/2025165.94 USD
9/15/2025164.34 USD
9/14/2025166.22 USD
9/11/2025167.99 USD
9/10/2025168.95 USD
9/9/2025166.15 USD
9/8/2025169.57 USD
9/7/2025174.12 USD
9/4/2025173.99 USD
9/3/2025173.00 USD
9/2/2025171.65 USD
9/1/2025172.53 USD
8/28/2025171.78 USD
8/27/2025172.60 USD
8/26/2025172.19 USD
8/25/2025170.68 USD
8/24/2025169.96 USD
8/21/2025172.44 USD
8/20/2025169.24 USD
8/19/2025169.01 USD
8/18/2025167.02 USD
8/17/2025164.06 USD
8/14/2025166.17 USD
8/13/2025166.00 USD
8/12/2025166.27 USD
8/11/2025163.54 USD
8/10/2025161.70 USD
8/7/2025160.63 USD
8/6/2025159.26 USD
8/5/2025158.13 USD
8/4/2025157.92 USD
8/3/2025154.94 USD
7/31/2025151.75 USD
7/30/2025150.00 USD
Access this data via the Eulerpool API
Get Free API Key

Ensign Group Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
2.63 B USD
260.47 M USD
194.65 M USD
Jan 1, 2022
3.03 B USD
296.83 M USD
224.68 M USD
Jan 1, 2023
3.73 B USD
263.52 M USD
209.40 M USD
Jan 1, 2024
4.26 B USD
358.30 M USD
297.97 M USD
Jan 1, 2025
5.06 B USD
425.31 M USD
343.97 M USD
Jan 1, 2026 (e)
5.84 B USD
536.21 M USD
439.43 M USD
Jan 1, 2027 (e)
6.44 B USD
590.58 M USD
484.29 M USD
Jan 1, 2028 (e)
7.04 B USD
646.18 M USD
530.85 M USD

Ensign Group Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 30, 2026, 6:43 PM
 
REVENUEB USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
DIV.USD
DIV. GROWTH%
SHARESM
20132014201520162017201820192020202120222023202420252026e2027e2028e
0.901.031.341.651.601.752.042.402.633.033.734.265.065.846.447.04
9.8413.6130.5723.34-3.399.7616.0817.989.3715.1523.2714.2418.7115.5410.139.42
18.1415.1913.8011.3710.7612.4314.2916.9417.8117.0915.8215.6615.8015.8015.8015.80
0.160.160.190.190.170.220.290.410.470.520.590.670.800.921.021.11
57.0072.0093.0091.0043.0084.00129.00223.00260.00296.00263.00358.00425.00536.00590.00646.00
6.317.016.945.502.694.796.349.289.909.797.058.408.409.179.179.17
24.0035.0055.0049.0040.0092.00110.00170.00194.00224.00209.00297.00343.00439.00484.00530.00
-40.0045.8357.14-10.91-18.37130.0019.5754.5514.1215.46-6.7042.1115.4927.9910.259.50
0.270.290.260.160.170.180.190.200.210.220.230.240.250.260.270.28
12.507.41-10.34-38.466.255.885.565.265.004.764.554.354.174.003.853.70
43.8844.8351.1452.2353.1854.9755.7656.3156.8455.6657.5658.5859.2959.2959.2959.29
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Ensign Group generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Ensign Group retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Ensign Group's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Ensign Group has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Ensign Group's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Ensign Group stock margins

The Ensign Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Ensign Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Ensign Group.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
17.82 %
9.91 %
7.41 %
Jan 1, 2022
17.12 %
9.81 %
7.43 %
Jan 1, 2023
15.84 %
7.07 %
5.61 %
Jan 1, 2024
15.67 %
8.41 %
6.99 %
Jan 1, 2025
15.81 %
8.41 %
6.80 %
Jan 1, 2026 (e)
15.81 %
9.18 %
7.52 %
Jan 1, 2027 (e)
15.81 %
9.18 %
7.53 %
Jan 1, 2028 (e)
15.81 %
9.18 %
7.54 %

Ensign Group Stock Revenue, EBIT, Earnings per Share

The Ensign Group earnings per share therefore indicates how much revenue Ensign Group has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
46.23 USD
4.58 USD
3.42 USD
Jan 1, 2022
54.36 USD
5.33 USD
4.04 USD
Jan 1, 2023
64.80 USD
4.58 USD
3.64 USD
Jan 1, 2024
72.73 USD
6.12 USD
5.09 USD
Jan 1, 2025
85.31 USD
7.17 USD
5.80 USD
Jan 1, 2026 (e)
100.55 USD
9.04 USD
7.56 USD
Jan 1, 2027 (e)
110.75 USD
9.96 USD
8.33 USD
Jan 1, 2028 (e)
121.17 USD
10.90 USD
9.14 USD

Ensign Group business model & stock analysis

The Ensign Group Inc. is an American company that was founded in 1999. Since then, it has become one of the leading providers of healthcare services in the US. The company is listed on the Nasdaq stock exchange and has its headquarters in San Juan Capistrano, California. The company was founded by founder and CEO Christopher Christensen, who had a clear vision of what he wanted to achieve with his own company. He founded Ensign to provide better care for patients and a better working environment for their caregivers. The company started as a small group of healthcare facilities and has since grown steadily. Today, the company operates over 250 facilities in various states across the US. The business model of Ensign is based on providing high-quality healthcare services for patients while building a financially viable company. The company operates various types of facilities, including nursing homes, rehabilitation centers, hospice facilities, and home health care facilities. Ensign offers a wide range of services, including rehabilitation, physical therapy, occupational therapy, speech therapy, and psychological counseling. The company is comprehensive in its approach and provides patients with comprehensive care both medically and in terms of nursing. Ensign has various divisions, including "The Pennant Group," which specializes in home health care services. In this division, nursing services are provided directly at the patient's home. The company also offers specialized hospice care and palliative medicine, focusing on the needs of patients with life-threatening illnesses. In addition, Ensign also offers rehabilitation services that focus on restoring the physical and mental health of patients. Ensign offers a wide range of products and services to meet the needs of its patients. In addition to medical and nursing services, the company also operates facilities that specialize in supporting people with intellectual or physical disabilities. The company also offers care products and materials to facilitate patient care. One of Ensign's most well-known products is the "Ensign Pulser," a medication delivery system designed for the needs of patients with heart conditions. In conclusion, The Ensign Group Inc. is a leading company in the field of healthcare services in the US. The company has a clear vision of providing high-quality care and a better working environment for nursing staff. Ensign's business model is based on providing comprehensive healthcare services in various facilities. Ensign will continue to play an important role in healthcare and help meet the needs of patients.

Ensign Group SWOT Analysis

Strengths

Ensign Group Inc has built a strong and recognized brand name within the industry, which helps in attracting clients and retaining a loyal customer base.

The company provides a wide range of healthcare services, including skilled nursing, assisted living, home health, and hospice care, which allows for multiple revenue streams and reduces dependency on a single market segment.

Ensign Group Inc has consistently demonstrated strong financial performance, with steady revenue growth, healthy profit margins, and effective cost management, providing stability and support for the organization's growth goals.

Weaknesses

The healthcare industry is highly competitive, and Ensign Group Inc faces competition from both traditional healthcare providers and new market entrants, which may impact its market share and growth potential.

As a healthcare company, Ensign Group Inc operates in a heavily regulated environment. Changes in healthcare policies, government regulations, or reimbursements could significantly impact the company's operations and financial performance.

Opportunities

With the increasing aging population, there is a growing demand for healthcare services, especially in the long-term care segment. Ensign Group Inc can capitalize on this opportunity by expanding its services and targeting this specific demographic.

Rapid advancements in healthcare technology provide opportunities for Ensign Group Inc to enhance service delivery, improve patient care, and optimize operational efficiencies. Embracing innovative technologies can give the company a competitive edge.

Threats

The escalating costs associated with healthcare services pose a threat to Ensign Group Inc, as it may lead to reduced reimbursement rates or increased expenses, impacting the company's profitability and financial viability.

The healthcare industry faces difficulties in recruiting and retaining qualified and skilled staff members. Ensign Group Inc may encounter challenges in maintaining a competent workforce, which could affect the quality of care provided.

Ensign Group Segments

Ensign Group Revenue by Segment (1/3)

  • 3 Years

  • 5 Years

  • Max

Health Care, Patient Service
Health Care, Resident Service
Details
Date
Service revenue
Service
Health Care, Patient Service
Health Care, Resident Service
Rental revenue
Rental
Jan 1, 2018
0.00 USD
0.00 USD
1.92 B USD
151.80 M USD
0.00 USD
0.00 USD

Ensign Group Revenue by Segment (2/3)

  • 3 Years

  • 5 Years

  • Max

Transitional and Skilled Services Segment
Assisted and Independent Living Services Segment
Details
Date
Transitional and Skilled Services Segment
Assisted and Independent Living Services Segment
Jan 1, 2018
1.68 B USD
151.80 M USD

Ensign Group Revenue by Segment (3/3)

  • 3 Years

  • 5 Years

  • Max

Home Health and Hospice Services
All Other
Details
Date
Home Health and Hospice Services
All Other
Jan 1, 2018
169.04 M USD
40.81 M USD

Ensign Group Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Ensign Group historical P/E ratio, EBIT multiple, and P/S ratio

Ensign Group annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Ensign Group shares outstanding

The number of shares of Ensign Group was 59.29 M in 2025. This indicates how many shares Ensign Group is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
56.84 M Stocks
Jan 1, 2022
55.66 M Stocks
Jan 1, 2023
57.56 M Stocks
Jan 1, 2024
58.58 M Stocks
Jan 1, 2025
59.29 M Stocks
Jan 1, 2026 (e)
59.29 M Stocks
Jan 1, 2027 (e)
59.29 M Stocks
Jan 1, 2028 (e)
59.29 M Stocks

Ensign Group stock splits

In Ensign Group's history, there have been no stock splits.

Ensign Group Dividend History

20 years of dividend payments · 9 consecutive increases

YearAnnual DividendYoY ChangePayments
20260.13USDYTD—2×
Mar 31, 20260.07USD 0.0%1/2
Jun 30, 20260.07USD 0.0%2/2
20250.25USD↑ 4.1%4×
Mar 31, 20250.06USD 0.0%1/4
Jun 30, 20250.06USD 0.0%2/4
Sep 30, 20250.06USD 0.0%3/4
Dec 31, 20250.07USD↑ 4.0%4/4
20240.24USD↑ 4.3%4×
20230.23USD↑ 4.5%4×
20220.22USD↑ 4.7%4×
20210.21USD↑ 4.9%4×
20200.20USD↑ 5.2%4×
20190.19USD↑ 5.5%4×
20180.18USD↑ 5.8%4×
20170.17USD↑ 6.2%4×

Ensign Group dividend history and estimates

In 2025, Ensign Group paid a dividend amounting to 0.25 USD. Dividend means that Ensign Group distributes a portion of its profits to its owners.

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2021
0.21 USD
0.00 USD
Jan 1, 2022
0.22 USD
0.00 USD
Jan 1, 2023
0.23 USD
0.00 USD
Jan 1, 2024
0.24 USD
0.00 USD
Jan 1, 2025
0.25 USD
0.00 USD
Jan 1, 2026 (e)
0.13 USD
0.13 USD
Jan 1, 2027 (e)
0.00 USD
0.27 USD
Jan 1, 2028 (e)
0.00 USD
0.28 USD

Ensign Group dividend payout ratio

In 2025, Ensign Group had a payout ratio of 4.35%. The payout ratio indicates the percentage of the company's profits that Ensign Group distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
6.21 %
Jan 1, 2022
5.51 %
Jan 1, 2023
6.39 %
Jan 1, 2024
4.77 %
Jan 1, 2025
4.35 %
Jan 1, 2026 (e)
3.44 %
Jan 1, 2027 (e)
3.26 %
Jan 1, 2028 (e)
3.11 %

Current Ensign Group forecasts and price targets in July 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy81.82 % (9)
Hold18.18 % (2)
Sell0.00 % (0)
12M Price Target
210.12
Last Price
181.70
Currency
USD
12M Return Potential
15.64 %
LTM Return
0 %

Ensign Group Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
7/23/20261.88USD1.47 BUSD2026 Q2
4/27/20261.85USD1.42 BUSD2026 Q1
4/23/20261.85USD1.42 BUSD2026 Q1
2/11/20261.80USD1.39 BUSD2025 Q4
2/3/20261.79USD1.39 BUSD2025 Q4
4/24/20241.28USD1.01 BUSD2024 Q1
1/31/20241.30USD995.23 MUSD2023 Q4
7/31/20231.18USD839.11 MUSD2023 Q2
4/26/20231.13USD821.47 MUSD2023 Q1
2/7/20231.12USD813.18 MUSD2022 Q4

EESG©

Eulerpool ESG Scorecard© for the Ensign Group stock

76/100
81
Environment
94
Social
53
Governance
E

Environment

20
Scope 1 - Direct Emissions—
Scope 2 - Indirect emissions from purchased energy—
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions—
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees78
Percentage of women in management—
Percentage of Asian employees11
Share of Asian management—
Percentage of Hispanic/Latino employees29
Hispano/Latino Management share—
Percentage of Black employees18
Black Management Share—
Percentage of white employees34
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Ensign Group shareholder structure

% Name
10.92028%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
10.52500%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
6.12403%
Wasatch Global Investors Inc
Wasatch Global Investors Inc
4.85047%
Baillie Gifford & Co.
Baillie Gifford & Co.
3.57711%
State Street Investment Management (US)
State Street Investment Management (US)
3.23497%
Capital Research Global Investors
Capital Research Global Investors
...

Ensign Group Executives and Management Board

BP

Mr. Barry Port

(50)

Chairman of the Board, Chief Executive Officer · since 2006

Compensation10.96 M USD
SS

Ms. Suzanne Snapper

(51)

Chief Financial Officer, Executive Vice President, Director · since 2007

Compensation9.49 M USD
SB

Mr. Spencer Burton

(46)

President, Chief Operating Officer - Ensign Services Inc

Compensation8.00 M USD
CK

Mr. Chad Keetch

(47)

Executive Vice President, Chief Investment Officer, Secretary

Compensation6.59 M USD
CC

Mr. Christopher Christensen

(56)

Executive Chairman of the Board, Co-Founder · since 1999

Compensation4.65 M USD

Frequently asked questions about Ensign Group

The business model of Ensign Group Inc focuses on providing a range of post-acute care services. As a leading healthcare provider, Ensign Group operates a network of skilled nursing facilities, assisted living centers, rehabilitative care centers, and other related services. They aim to deliver high-quality and personalized care to improve the lives of patients and support their recovery journey. Ensign Group's business model prioritizes patient-centered care, employee empowerment, and strong partnerships with healthcare organizations. By offering a comprehensive suite of healthcare services, Ensign Group Inc aims to meet the evolving needs of patients and ensure their well-being across their facilities.

All fundamentals and in-depth analysis of Ensign Group

Our stock analysis for Ensign Group stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ensign Group. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Ensign Group Stock
Ensign Group Revenue→
Ensign Group Stock
Ensign Group Net Income→
Ensign Group Stock
Ensign Group P/E→
Ensign Group Stock
Ensign Group P/S→
Ensign Group Stock
Ensign Group EBIT→
Ensign Group Stock
Ensign Group Dividend→
Ensign Group Stock
Ensign Group Directors Dealings→
Ensign Group Stock
Ensign Group Stocks→
Ensign Group Stock
Ensign Group Market capitalization→
Ensign Group Stock
Ensign Group Debt→
Ensign Group Stock
Ensign Group Liabilities→
Ensign Group Stock
Ensign Group Equity→
Ensign Group Stock
Ensign Group AAQS→
Ensign Group Stock
Ensign Group Employees→
Ensign Group Stock
Ensign Group ROE→
Ensign Group Stock
Ensign Group ROA→
Ensign Group Stock
Ensign Group ROCE→
Ensign Group Stock
Ensign Group News→
Ensign Group Stock
Ensign Group Analyst Price Targets→

Health Stocks

Ensysce BiosciencesEnseval Putera Megatrading Tbk PTEntera BioEnovisEntero Healthcare SolutionsEnorama PharmaEntrada TherapeuticsEnlivex TherapeuticsEntropy NeurodynamicsEnliven TherapeuticsEnveric BiosciencesEnimmuneAll Stocks A–Z →